Evidence map›Paper›PMID 21297630›Full record

ArticleNature neuroscience2011

NR3A-containing NMDARs promote neurotransmitter release and spike timing-dependent plasticity.

Rylan S Larsen, Rebekah J Corlew, Maile A Henson, Adam C Roberts, Masayoshi Mishina, Masahiko Watanabe, Stuart A Lipton, Nobuki Nakanishi, Isabel Pérez-Otaño, Richard J Weinberg and 1 more

Open access · greenAbstract read
In one paragraph

Article in Nature neuroscience, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 153 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. GluN3A and Excitatory Glycine Receptors in the Adult Hippocampus.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  6. Structural prediction of GluN3 NMDA receptors.Frontiers in physiology · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Frontiers in synaptic neuroscience · 2022
    Review
  12. Synaptic NMDA receptor activity at resting membrane potentials.Frontiers in cellular neuroscience · 2022
    Article
  13. Article
  14. Advances and Barriers in Understanding PresynapticFrontiers in molecular neuroscience · 2022
    Review
  15. Article
  16. Article
  17. The roles of GluN3-containing N-methyl-D-aspartate receptor in central nerve system.Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2021
    Review
  18. Review
  19. Article
  20. Article

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Rylan S LarsenDepartment of Cell and Molecular Physiology, University of North Carolina, Chapel Hill, North Carolina, USA.
Rebekah J Corlew
Maile A Henson
Adam C Roberts
Masayoshi Mishina
Masahiko Watanabe
Stuart A Lipton
Nobuki Nakanishi
Isabel Pérez-Otaño
Richard J Weinberg
Benjamin D Philpot
University of North Carolina at Chapel Hill · USSanford Burnham Prebys Medical Discovery Institute · USHokkaido University · JPThe University of Tokyo · JPUniversidad de Navarra · ES

Funding

PROJECT III - GENETIC APPROACH TO EXCITATORY TRANSMISSIONP01HD029587 · NICHD · SCINTILLON INSTITUTE FOR PHOTOBIOLOGY · PI ZHANG, DONGXIAN · 1992 to 2016
$21.9M
Postdoctoral Research in Neurodevelopmental DisordersT32HD040127 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BENJAMIN D PHILPOT, Mark D Shen · 2001 to 2026
$8.5M
The Supramolecular Architecture of the Postsynaptic DensityR01NS039444 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WEINBERG, RICHARD J · 2000 to 2021
$6.1M
RETINAL GANGLION CELLS: ION CHANNEL &TRANSMITTERSR01EY005477 · NEI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI LIPTON, STUART A · 1985 to 2010
$5.0M
CA++ CHANNEL ANTAGONISTS AND AIDS-RELATED NEUROTOXICITYR01EY009024 · NEI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI LIPTON, STUART A · 1991 to 2009
$3.9M
Mechanisms of Presynaptic Plasticity in Visual CortexR01EY018323 · NEI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI PHILPOT, BENJAMIN D · 2007 to 2011
$1.8M
Subtype-Specific Roles of Presynaptic-Acting NMDA ReceptorsF31MH091817 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LARSEN, RYLAN SCOTT · 2011 to 2013
$74k
MINORITY PREDOCTORAL FELLOWSHIP PROGRAMF31GM080162 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CORLEW, REBEKAH J · 2007 to 2008
$54k
NEI NIH HHS R01 EY005477NEI NIH HHS R01 EY009024NEI NIH HHS R01 EY018323NEI NIH HHS R01 EY05477NEI NIH HHS R01 EY09024NICHD NIH HHS P01 HD029587NICHD NIH HHS P01 HD29587NICHD NIH HHS T32 HD040127NICHD NIH HHS T32 HD40127NIGMS NIH HHS F31 GM080162NIMH NIH HHS F31 MH091817NINDS NIH HHS R01 NS039444NINDS NIH HHS R01 NS39444
6 · The paper itself

Abstract

Recent evidence suggests that presynaptic-acting NMDA receptors (preNMDARs) are important for neocortical synaptic transmission and plasticity. We found that unique properties of the NR3A subunit enable preNMDARs to enhance spontaneous and evoked glutamate release and that NR3A is required for spike timing-dependent long-term depression in the juvenile mouse visual cortex. In the mature cortex, NR2B-containing preNMDARs enhanced neurotransmission in the absence of magnesium, indicating that presynaptic NMDARs may function under depolarizing conditions throughout life. Our findings indicate that NR3A relieves preNMDARs from the dual-activation requirement of ligand-binding and depolarization; the developmental removal of NR3A limits preNMDAR functionality by restoring this associative property.

Indexed as

Action PotentialsAnimalsExcitatory Postsynaptic PotentialsGlutamic AcidLong-Term Synaptic DepressionMagnesiumMiceMice, TransgenicNeuronal PlasticityNeurotransmitter AgentsProtein SubunitsReceptors, N-Methyl-D-AspartateSynaptic TransmissionTime FactorsGlutamic AcidMagnesiumNeurotransmitter AgentsNR3A NMDA receptorProtein SubunitsReceptors, N-Methyl-D-Aspartate

Identifiers

PMID21297630
PMCPMC3474337
OpenAlexW2009847863

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.